2018
DOI: 10.1186/s12936-018-2551-7
|View full text |Cite
|
Sign up to set email alerts
|

Towards a re-emergence of chloroquine sensitivity in Côte d’Ivoire?

Abstract: BackgroundResistance of Plasmodium falciparum to anti-malarial drugs has hampered efforts to eradicate malaria. Recent reports of a decline in the prevalence of chloroquine-resistant P. falciparum in several countries, including Malawi and Zambia, is raising the hope of reintroducing chloroquine in the near future, ideally in combination with another anti-malarial drug for the treatment of uncomplicated malaria. In Côte d’Ivoire, the decrease in the clinical efficacy of chloroquine, in addition to a high propo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

6
15
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(21 citation statements)
references
References 28 publications
(28 reference statements)
6
15
0
Order By: Relevance
“…This may be a result of the withdrawal of chloroquine and the introduction of ACT in 2006 in Kenya, which may have promoted the re-emergence of chloroquine-sensitive isolates. This is consistent with other studies conducted in Kenya [ 49 , 58 ], Malawi [ 59 ], Côte d’Ivoire [ 60 ], and Tanzania [ 8 ], which have reported re-emergence of chloroquine-susceptible parasites following years of discontinuation of chloroquine use. A small proportion of parasites (< 5%) contained a mixed (N75 D ) or mutated (75 E ) nucleotide at codon 75, yielding haplotypes CV IDT , CVM DT , and CV IET .…”
Section: Discussionsupporting
confidence: 92%
“…This may be a result of the withdrawal of chloroquine and the introduction of ACT in 2006 in Kenya, which may have promoted the re-emergence of chloroquine-sensitive isolates. This is consistent with other studies conducted in Kenya [ 49 , 58 ], Malawi [ 59 ], Côte d’Ivoire [ 60 ], and Tanzania [ 8 ], which have reported re-emergence of chloroquine-susceptible parasites following years of discontinuation of chloroquine use. A small proportion of parasites (< 5%) contained a mixed (N75 D ) or mutated (75 E ) nucleotide at codon 75, yielding haplotypes CV IDT , CVM DT , and CV IET .…”
Section: Discussionsupporting
confidence: 92%
“…The most common quintuple haplotypes identified in Pfcrt gene were CVMNK and CVIET. This concords with previously published studies in other regions [ 101 , 102 ]. It is important to note that one study reported the presence of Pfcrt SVMNT haplotype with a prevalence of 4.4% [ 59 ], which is lower than the 19.0% [ 15 ] and 56.9% [ 14 ] reported in the Korogwe District, Tanzania and Luanda, Angola, respectively.…”
Section: Discussionsupporting
confidence: 90%
“…Similar findings associating resistance markers with CQ use have been reported elsewhere: persisting high levels of mutant Pfcrt haplotypes in infections from Brazil and, in contrast, the reappearance of wild type forms in Nigeria have been attributed to differences in the selective pressure by CQ use (Gbotosho et al, 2012). Moreover, the slow reappearance of CQ sensitive parasites harboring Pfcrt -K76 haplotype in low P. vivax prevalence areas of Gambella and Benishangul-Gumuz corroborates observations from other African countries such as Malawi (Kublin et al, 2003), Côte d’Ivoire (Dagnogo et al, 2018), Zambia (Mwanza et al, 2016),Tanzania (Mohammed et al, 2013) and Kenya (Achieng et al, 2015).…”
Section: Discussionsupporting
confidence: 83%